Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: A meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Huang, Jian ^a   Yang, Yaqi ^a   Liang, Zibin ^a   Kang, Miaomiao ^a   Kuang, Ying ^a   Li, Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN;

ALLELE; AMINO ACID SUBSTITUTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; MULTIPLE SCLEROSIS; ODDS RATIO; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; AMINO ACID SUBSTITUTION; ANTIGENS, CD24; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84926431797     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09557     Document Type: Article

References (38)

1. Azevedo, P. C., Murphy, G. & Isenberg, D. A. Pathology of systemic lupus erythematosus: the challenges ahead. Methods Mol Biol. 1134, 1-16 (2014).
2. Ciccarelli, O. et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol. 13, 807-822 (2014).
3. Lettre, G. & Rioux, J. D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet. 17, R116-121 (2008).
4. Allen, M. et al. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol. 39, 41-48 (1994).
5. Deng, Y. & Tsao, B. P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol. 6, 683-692 (2010).
6. Watson, C. T., Disanto, G., Breden, F., Giovannoni, G. & Ramagopalan, S. V. Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs. Sci Rep. 2, 770 (2012).
7. Wang, C. M. et al. Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep. 4, 3792. (2014).
8. Liu, Y., Jones, B., Brady, W., Janeway, C. A. Jr. & Linsley, P. S. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur J Immunol. 22, 2855-2859 (1992).
9. Nielsen, P. J. et al. Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient Mice. Blood. 89, 1058-1067 (1997).
10. Bai, X. F. et al. CD24 Controls expansion and persistence of autoreactive T Cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med. 200, 447-458 (2004).
11. Ahmed, M. A. et al. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. J Clin Pathol. 62, 1117-1122 (2009).
12. Zhang, X. et al. CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes. Eur J Immunol. 42, 924-935 (2012).
13. Liu, Y., Wenger, R. H., Zhao, M. & Nielsen, P. J. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med. 185, 251-262 (1997).
14. Hough, M. R. et al. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen. J Immunol. 156, 479-488 (1996).
15. Hahne, M., Wenger, R. H., Vestweber, D. & Nielsen, P. J. The heat-stable antigen can alter very late antigen 4-mediated adhesion. J Exp Med. 179, 1391-1395 (1994).
16. Zarn, J. A. et al. The small cell lung cancer antigen cluster-4 and the leukocyte antigen CD24 are allelic isoforms of the same gene (CD24) on chromosome band 6q21. Cytogenet Cell Genet. 70, 119-125 (1995).
17. Zhou, Q. et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A. 100, 15041-15046 (2003).
18. Cui, Y. Z. et al. Study on the association between CD24 gene polymorphisms and multiple sclerosis. Zhongfeng Yu Shen Jing Ji Bing Za Zhi 23, 155-157 (2006). Chinese.
19. Otaegui, D. et al. CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Mult Scler. 12, 511-514 (2006).
20. Sánchez, E. et al. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 56, 3080-3086 (2007).
21. Ronaghi, M., Vallian, S. & Etemadifar, M. CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population. Psychiatry Res. 170, 271-272 (2009).
22. Piotrowski, P., Lianeri, M., Wudarski, M., Łacki, J. K. & Jagodziński, P. P. CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus. Tissue Antigens. 75, 696-700 (2010).
23. González, S. J. et al. CD24 as a genetic modifier of disease progression in multiple sclerosisin Argentinean patients. J Neurol Sci. 307, 18-21 (2011).
24. Kollaee, A., Ghaffarpor, M., Pourmahmoudian, H., Shahbazi, M. & Zamani, M. Investigation of CD24 and its expression in Iranian relapsing-remittingmultiple sclerosis. Int J Neurosci. 121, 684-690 (2011).
25. Gao, H., Song, J. Q. & Wang, J. Association of CD24 gene polymorphisms with systemic lupus erythematosus. Wuhan Da Xue Xue Bao (Yi Xue Ban) 35, 765-768 (2014). Chinese.
26. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D. & Attia, J. Amethod formetaanalysis of molecular association studies. Stat Med. 24, 1291-1306 (2005).
27. Der Simonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials. 7, 177-188 (1986).
28. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22, 719-748 (1959).
29. McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 50, 121-127 (2001).
30. Poser, C. M. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 13, 227-231 (1983).
31. Hochberg, M. C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1997).
32. Lu, X. et al. Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects. Sci Rep. 4, 3924 (2014).
33. Liu, Y. & Zheng, P. CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseases. Trends Immunol. 28, 315-320 (2007).
34. Suzuki, T. et al. CD24 induces apoptosis in human B cells via the glycolipidenriched membrane domains/rafts-mediated signaling system. J Immunol. 166, 5567-5577 (2001).
35. Bai, X. F. et al. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J Clin Invest. 105, 1227-1232 (2000).
36. Liu, J. Q. et al. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. J Immunol. 178, 6227-6235 (2007).
37. Carl, J. W. Jr. et al. Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. J Immunol. 181, 320-328 (2008).
38. Wither, J. E., Paterson, A. D. & Vukusic, B. Genetic dissection of B cell traits in New Zealand black mice. The expanded population of B cells expressing upregulated costimulatory molecules shows linkage to Nba2. Eur J Immunol. 30, 356-365 (2000).